- Home
- PIPR vs GRFS Comparison
PIPR vs GRFS Comparison
Compare PIPR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIPR
- GRFS
- Stock Information
- Founded
- PIPR 1895
- GRFS 1940
- Country
- PIPR United States
- GRFS Spain
- Employees
- PIPR N/A
- GRFS N/A
- Industry
- PIPR Investment Bankers/Brokers/Service
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- PIPR Finance
- GRFS Health Care
- Exchange
- PIPR Nasdaq
- GRFS Nasdaq
- Market Cap
- PIPR 4.9B
- GRFS 5.1B
- IPO Year
- PIPR N/A
- GRFS 2006
- Fundamental
- Price
- PIPR $247.78
- GRFS $7.73
- Analyst Decision
- PIPR Hold
- GRFS Strong Sell
- Analyst Count
- PIPR 3
- GRFS 1
- Target Price
- PIPR $330.00
- GRFS N/A
- AVG Volume (30 Days)
- PIPR 140.3K
- GRFS 1.4M
- Earning Date
- PIPR 04-25-2025
- GRFS 01-01-0001
- Dividend Yield
- PIPR 2.19%
- GRFS N/A
- EPS Growth
- PIPR 106.45
- GRFS 283.33
- EPS
- PIPR 10.24
- GRFS 0.24
- Revenue
- PIPR $1,525,914,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- PIPR $18.29
- GRFS $8.45
- Revenue Next Year
- PIPR $13.91
- GRFS $7.08
- P/E Ratio
- PIPR $24.46
- GRFS $38.72
- Revenue Growth
- PIPR 13.20
- GRFS 9.41
- 52 Week Low
- PIPR $183.58
- GRFS $5.68
- 52 Week High
- PIPR $351.80
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- PIPR 33.45
- GRFS 49.38
- Support Level
- PIPR $241.72
- GRFS $8.21
- Resistance Level
- PIPR $292.68
- GRFS $8.81
- Average True Range (ATR)
- PIPR 9.37
- GRFS 0.43
- MACD
- PIPR -3.11
- GRFS -0.04
- Stochastic Oscillator
- PIPR 22.44
- GRFS 41.34
About PIPR Piper Sandler Companies
Piper Sandler Cos is an investment banking company. Investment banking services include financial advisory services, management of and participation in underwriting, and public finance activities. It generates maximum revenue from Advisory services followed by Equity financing. The company focuses on the following sectors: healthcare; energy; consumer; diversified industrials and services; business services; technology; financial services; agriculture, clean technologies, and renewables, focusing on middle-market clients.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.